The voluntary recall was initiated by Nishimoto Trading Company, Ltd. of Santa Fe Springs, California, after being advised by CDPH that routine surveillance tests conducted by the Virginia Department of Agriculture and Consumer Services identified that the products contained as much as 113 parts per million (ppm) and 43 ppm of sulfites, respectively.
Foods containing more than 10 ppm of sulfites are required to disclose the presence of sulfites on the product label.
The Shirakiku Brand Dried Shiitake Whole Mushrooms are packed in a three-ounce plastic rectangular package with gold and black border with the word SHII-TA-KE” in red lettering at the top of the clear panel. The red and white Shirakiku Brand logo is in the top border.
The whole dried mushrooms are visible through a clear panel on the front of the package.
The Shirakiku Brand Dried Shiitake Sliced Mushrooms are packed in a two-ounce clear plastic rectangular package with the red and white Shirakiku Brand logo at the top.
A white rectangular panel with black and red Japanese characters and an illustration of two mushrooms is on the front of the package. The sliced dried mushrooms are visible through the packaging.
People who have severe sensitivity to sulfites and some asthmatics may run the risk of serious or life-threatening reactions, including but not limited to anaphylactic shock if they consume these products.
Consumers in possession of these products should throw them away or return them to the place of purchase for a refund, and call CDPH’s Complaint Hotline at 1-800-495-3232 if these products are being offered for sale.
Consumers in possession of these candies should discard immediately. Recent analysis of these candies by CDPH determined that Bee Sunny Day Gummies candy contained as much as 0.18 parts per million (ppm) of lead and BAVAN Mix Goli candy contained as much as 0.22 ppm of lead. California considers candies with lead levels in excess of 0.10 ppm to be contaminated.
Bee Sunny Day Gummies candy is sold in a 3.53 ounce (100 gram) package. The package is orange and yellow with orange writing stating “Sunny Day Gummies” on the front with pictures of various insects and flowers.
The package contains 10 pieces of “gummie” candy each wrapped in plastic with the wording ‘Sunny Day Gummies’.
Bavan Mix Goli candy is sold in a 14 ounce (400 gram) clear plastic package with an orange and white label. The candy is visible through the package.
The candies are crescent-shaped and come in various colors (red, blue, green, yellow, orange, and white).
The brand name BAVAN is at the top of the label and “Candy (Mix goli)” is in the middle of the label.
The distributors of these candies are working with CDPH to ensure the contaminated candies are removed from the marketplace.
Consumers who find any of these candies for sale are encouraged to call the CDPH Complaint Hotline at 1-800-495-3232.
Pregnant women and parents of children who may have consumed this candy should consult their physician or health care provider to determine if medical testing is needed.
Assemblywoman Ma was presented with the award at the National Multiple Sclerosis Society’s annual meeting on Nov. 13.
The Northern California Chapter of NMSS recognized Assemblywoman Ma for her hard-fought efforts and dedicated advocacy in addressing the challenges faced by each person affected by MS.
Assemblywoman Ma’s AB 310 serves as landmark patient protection legislation which would make medication that falls into the “specialty tiers” category of health insurance more affordable for patients.
This bill would also prevent insurers from shifting the cost of expensive medication to California patients by placing a cap on co-pays, and limiting the annual out-of-pocket expenditures.
For patients suffering from chronic medical conditions such as Multiple Sclerosis, the added financial burden of specialty tiers can be cumbersome.
AB 310 is currently in Assembly Appropriations Committee and will be amended. For more information on AB 310, please visit www.leginfo.ca.gov.
For more information on the Northern California Chapter of the National Multiple Sclerosis Society (NMSS), please visit http://www.nationalmssociety.org/chapters/CAN/index.aspx.
This adds to Medicare’s existing portfolio of preventive services that are now available without cost sharing under the Affordable Care Act.
It complements the Million Hearts initiative led jointly by CMS and the Centers for Disease Control and Prevention in partnership with other HHS agencies, communities, health systems, nonprofit organizations, and private sector partners across the country to prevent one million heart attacks and strokes in the next five years.
“Obesity is a challenge faced by Americans of all ages, and prevention is crucial for the management and elimination of obesity in our country,” said CMS Administrator Donald M. Berwick, MD. “It’s important for Medicare patients to enjoy access to appropriate screening and preventive services.”
More than 30 percent of both men and women in the Medicare population are estimated to be obese. Obesity is directly or indirectly associated with many chronic diseases, including those that disproportionately affect racial and ethnic minorities such as cardiovascular disease and diabetes.
Addressing the prevention of obesity related disparities has the potential to reduce obesity prevalence while also closing the gap on health disparities among Medicare beneficiaries.
Screening for obesity and counseling for eligible beneficiaries by primary care providers in settings such as physicians’ offices are covered under this new benefit.
For a beneficiary who screens positive for obesity with a body mass index (BMI) ≥ 30 kg/m2, the benefit would include one face-to-face counseling visit each week for one month and one face-to-face counseling visit every other week for an additional five months.
The beneficiary may receive one face-to-face counseling visit every month for an additional six months (for a total of 12 months of counseling) if he or she has achieved a weight reduction of at least 6.6 pounds (or 3 kilograms) during the first six months of counseling.
“This decision is an important step in aligning Medicare’s portfolio of preventive services with evidence and addressing risk factors for disease,” said Patrick Conway, MD, MSc, CMS Chief Medical Officer and Director of the Agency’s Office of Clinical Standards and Quality. “We at CMS are carefully and systematically reviewing the best available medical evidence to identify those preventive services that can keep Medicare beneficiaries as healthy as possible for as long as possible.”
Through the end of October, 22.6 million people with Original Medicare have received one or more of the free covered preventive services this year.
To read the final decision on the new national coverage determination, visit the CMS website at: http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?&NcaName=Intensive%20Behavioral%20Therapy%20for%20Obesity&bc=ACAAAAAAIAAA&NCAId=253& .
For more information about Million Hearts, please visit www.millionhearts.hhs.gov.